Verified peer comparison
BGC Group, Inc. - Class A Common Stock vs Amneal Pharmaceuticals, Inc. - Class A Common Stock Financial Comparison
BGC Group, Inc. - Class A Common Stock versus Amneal Pharmaceuticals, Inc. - Cl…
Direct answer
BGC Group, Inc. - Class A Common Stock and Amneal Pharmaceuticals, Inc. - Class A Common Stock are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free BGC Group, Inc. - Class A Common Stock email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- BGC Group, Inc. - Class A Common Stock Revenue
- 3,008,178,000 USD
- Amneal Pharmaceuticals, Inc. - Class A Common Stock Revenue
- 3,018,760,000 USD
- BGC Group, Inc. - Class A Common Stock Operating income
- 316,325,000 USD
- Amneal Pharmaceuticals, Inc. - Class A Common Stock Operating income
- 423,090,000 USD